Developmental minocycline treatment reverses the effects of neonatal immune activation on anxiety- and depression-like behaviors, hippocampal inflammation, and HPA axis activity in adult mice

Brain Research Bulletin

Volumn 120, Issue , 2016, Pages 1-13

  Majidi, Jafar ^a   Kosari Nasab, Morteza ^a   Salari, Ali Akbar ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TABRIZ   (Iran)

Author keywords

Affective disorders; Brain development; Hippocampal inflammation; HPA axis activity; Neonatal infection; Proinflammatory cytokines

Indexed keywords

CORTICOSTERONE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MINOCYCLINE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; WATER; ANTIINFECTIVE AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; ENCEPHALITIS; ENVIRONMENTAL EXPOSURE; FEMALE; HIPPOCAMPUS; HYPOPHYSIS ADRENAL SYSTEM; LACTATION; MALE; MOUSE; NEUROLOGIC DISEASE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROGENY; SECOND CERVICAL VERTEBRA; STRESS; ANIMAL; ANXIETY DISORDERS; DEPRESSIVE DISORDER; DISEASE MODEL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; INFLAMMATION; PATHOPHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; ANXIETY DISORDERS; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; FEMALE; HIPPOCAMPUS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; LACTATION; LIPOPOLYSACCHARIDES; MALE; MICE; MINOCYCLINE; PITUITARY-ADRENAL SYSTEM;

EID: 84946434590     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2015.10.009     Document Type: Article

References (92)

1. Amani M., Samadi H., Doosti M.-H., Azarfarin M., Bakhtiari A., Majidi-Zolbanin N., Mirza-Rahimi M., Salari A.-A. Neonatal NMDA receptor blockade alters anxiety- and depression-related behaviors in a sex-dependent manner in mice. Neuropharmacology 2013, 73:87-97.
2. Babri S., Doosti M.-H., Salari A.-A. Strain-dependent effects of prenatal maternal immune activation on anxiety- and depression-like behaviors in offspring. Brain Behav. Immun. 2014, 37:164-176.
3. Babri S., Doosti M.-H., Salari A.-A. Tumor necrosis factor-alpha during neonatal brain development affects anxiety- and depression-related behaviors in adult male and female mice. Behav. Brain Res. 2014, 261:305-314.
4. Bayramgürler D., Karson A., Özer C., Utkan T. Effects of long-term etanercept treatment on anxiety- and depression-like neurobehaviors in rats. Physiol. Behav. 2013, 119:145-148.
5. Ben-Hur T., Ben-Menachem O., Furer V., Einstein O., Mizrachi-Kol R., Grigoriadis N. Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells. Mol. Cell. Neurosci. 2003, 24:623-631.
6. Bilbo S.D., Biedenkapp J.C., Der-Avakian A., Watkins L.R., Rudy J.W., Maier S.F. Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. J. Neurosci. 2005, 25:8000-8009.
7. Bilbo S.D., Levkoff L.H., Mahoney J.H., Watkins L.R., Rudy J.W., Maier S.F. Neonatal infection induces memory impairments following an immune challenge in adulthood. Behav. Neurosci. 2005, 119:293.
8. Bilousova T., Dansie L., Ngo M., Aye J., Charles J.R., Ethell D.W., Ethell I.M. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J. Med. Genet. 2009, 46:94-102.
9. Bland S.T., Beckley J.T., Young S., Tsang V., Watkins L.R., Maier S.F., Bilbo S.D. Enduring consequences of early-life infection on glial and neural cell genesis within cognitive regions of the brain. Brain Behav. Immun. 2010, 24:329-338.
10. Boksa P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav. Immun. 2010, 24:881-897.
11. Borsini A., Zunszain P.A., Thuret S., Pariante C.M. The role of inflammatory cytokines as key modulators of neurogenesis. Trends Neurosci. 2015, 38:145-157.
12. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., Charney D.S. Hippocampal volume reduction in major depression. Am. J. Psychiatry 2000, 157(1):115-118.
13. Cacci E., Claasen J.H., Kokaia Z. Microgliaderived tumor necrosis factor-α exaggerates death of newborn hippocampal progenitor cells in vitro. J. Neurosci. Res. 2005, 80:789-797.
14. Cai Z., Lin S., Fan L.-W., Pang Y., Rhodes P. Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain. Neuroscience 2006, 137:425-435.
15. Chen J., Song Y., Yang J., Zhang Y., Zhao P., Zhu X.-J., Su H.-c. The contribution of TNF-α in the amygdala to anxiety in mice with persistent inflammatory pain. Neurosci. Lett. 2013, 541:275-280.
16. Cheng S., Hou J., Zhang C., Xu C., Wang L., Zou X., Yu H., Shi Y., Yin Z., Chen G. Minocycline reduces neuroinflammation but does not ameliorate neuron loss in a mouse model of neurodegeneration. Sci. Rep. 2015, 5:10535.
17. Cottrell E.C., Seckl J.R. Prenatal stress, glucocorticoids and the programming of adult disease. Front. Behav. Neurosci. 2009, 3.
18. Dansie L., Phommahaxay K., Okusanya A., Uwadia J., Huang M., Rotschafer S., Razak K., Ethell D., Ethell I. Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice. Neuroscience 2013, 246:186-198.
19. Das S., Basu A. Inflammation: a new candidate in modulating adult neurogenesis. J. Neurosci. Res. 2008, 86:1199-1208.
20. Depino A. Early prenatal exposure to LPS results in anxiety-and depression-related behaviors in adulthood. Neuroscience 2015, 299:56-65.
21. Dickerson D.D., Restieaux A.M., Bilkey D.K. Clozapine administration ameliorates disrupted long-range synchrony in a neurodevelopmental animal model of schizophrenia. Schizophr. Res. 2012, 135:112-115.
22. Dong E., Dzitoyeva S.G., Matrisciano F., Tueting P., Grayson D.R., Guidotti A. Brain-derived neurotrophic factor epigenetic modifications associated with schizophrenia-like phenotype induced by prenatal stress in mice. Biol. Psychiatry 2015, 77:589-596.
23. Doosti M.-H., Bakhtiari A., Zare P., Amani M., Majidi-Zolbanin N., Babri S., Salari A.-A. Impacts of early intervention with fluoxetine following early neonatal immune activation on depression-like behaviors and body weight in mice. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2013, 43:55-65.
24. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctôt K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
25. Ekdahl C., Kokaia Z., Lindvall O. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 2009, 158:1021-1029.
26. Enayati M., Solati J., Hosseini M.-H., Shahi H.-R., Saki G., Salari A.-A. Maternal infection during late pregnancy increases anxiety-and depression-like behaviors with increasing age in male offspring. Brain Res. Bull. 2012, 87:295-302.
27. Engin E., Treit D. The role of hippocampus in anxiety: intracerebral infusion studies. Behav. Pharmacol. 2007, 18:365-374.
28. Fan L.-W., Pang Y., Lin S., Rhodes P., Cai Z. Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neuroscience 2005, 133:159-168.
29. Fan L.W., Pang Y., Lin S., Tien L.T., Ma T., Rhodes P.G., Cai Z. Minocycline reduces lipopolysaccharideinduced neurological dysfunction and brain injury in the neonatal rat. J. Neurosci. Res. 2005, 82:71-82.
30. Fried E.I., Nesse R.M. Depression sum-scores don't add up: why analyzing specific depression symptoms is essential. BMC Med. 2015, 13:72.
31. Garrido-Mesa N., Zarzuelo A., Galvez J. What is behind the non-antibiotic properties of minocycline?. Pharmacol. Res. 2013, 67:18-30.
32. Goshen I., Kreisel T., Ben-Menachem-Zidon O., Licht T., Weidenfeld J., Ben-Hur T., Yirmiya R. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol. Psychiatry 2008, 13:717-728.
33. Hannestad J., DellaGioia N., Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 2011, 36:2452-2459.
34. Henry C.J., Huang Y., Wynne A., Hanke M., Himler J., Bailey M.T., Sheridan J.F., Godbout J.P. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J. Neuroinflamm. 2008, 5:2094-2095.
35. Herman J.P., Ostrander M.M., Mueller N.K., Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2005, 29:1201-1213.
36. Huppert J.D., Weiss K.A., Lim R., Pratt S., Smith T.E. Quality of life in schizophrenia: contributions of anxiety and depression. Schizophr. Res. 2001, 51:171-180.
37. Iosif R.E., Ekdahl C.T., Ahlenius H., Pronk C.J., Bonde S., Kokaia Z., Jacobsen S.-E.W., Lindvall O. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J. Neurosci. 2006, 26:9703-9712.
38. Ishiwata H., Shiga T., Okado N. Selective serotonin reuptake inhibitor treatment of early postnatal mice reverses their prenatal stress-induced brain dysfunction. Neuroscience 2005, 133:893-901.
39. Järlestedt K., Naylor A., Dean J., Hagberg H., Mallard C. Decreased survival of newborn neurons in the dorsal hippocampus after neonatal LPS exposure in mice. Neuroscience 2013, 253:21-28.
40. Jiang Y., Liu Y., Zhu C., Ma X., Ma L., Zhou L., Huang Q., Cen L., Pi R., Chen X. Minocycline enhances hippocampal memory, neuroplasticity and synapse-associated proteins in aged C57 BL/6 mice. Neurobiol. Learn. Mem. 2015, 121:20-29.
41. Karson A., Demirtaş T., Bayramgürler D., Balci F., Utkan T. Chronic administration of infliximab (TNFα Inhibitor) decreases depression and anxietylike behaviour in rat model of chronic mild stress. Basic Clin. Pharmacol. Toxicol. 2013, 112:335-340.
42. Kaster M.P., Gadotti V.M., Calixto J.B., Santos A.R., Rodrigues A.L.S. Depressive-like behavior induced by tumor necrosis factor-α in mice. Neuropharmacology 2012, 62:419-426.
43. Kinney D.K., Munir K.M., Crowley D.J., Miller A.M. Prenatal stress and risk for autism. Neurosci. Biobehav. Rev. 2008, 32:1519-1532.
44. Kohman R.A., Rhodes J.S. Neurogenesis, inflammation and behavior. Brain Behav. Immun. 2013, 27:22-32.
45. Koo J.W., Duman R.S. Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neurosci. Lett. 2009, 456:39-43.
46. Kreisel T., Frank M., Licht T., Reshef R., Ben-Menachem-Zidon O., Baratta M., Maier S., Yirmiya R. Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol. Psychiatry 2014, 19:699-709.
47. Krügel U., Fischer J., Radicke S., Sack U., Himmerich H. Antidepressant effects of TNF-α blockade in an animal model of depression. J. Psychiatr. Res. 2013, 47:611-616.
48. Lee C.Z., Yao J.S., Huang Y., Zhai W., Liu W., Guglielmo B.J., Lin E., Yang G.-Y., Young W.L. Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation. J. Cereb. Blood Flow Metab. 2006, 26:1157-1164.
49. Lin S., Wei X., Bales K.R., Paul A.B., Ma Z., Yan G., Paul S.M., Du Y. Minocycline blocks bilirubin neurotoxicity and prevents hyperbilirubinemiainduced cerebellar hypoplasia in the Gunn rat. Eur. J. Neurosci. 2005, 22:21-27.
50. Loftis J.M., Huckans M., Morasco B.J. Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol. Dis. 2010, 37:519-533.
51. Löwe B., Spitzer R.L., Williams J.B., Mussell M., Schellberg D., Kroenke K. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen. Hosp. Psychiatry 2008, 30:191-199.
52. Luzi P., Abraham R.M., Rafi M.A., Curtis M., Hooper D.C., Wenger D.A. Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy. Brain Res. 2009, 1300:146-158.
53. Majidi-Zolbanin J., Azarfarin M., Samadi H., Enayati M., Salari A.-A. Adolescent fluoxetine treatment decreases the effects of neonatal immune activation on anxiety-like behavior in mice. Behav. Brain Res. 2013, 250:123-132.
54. Majidi-Zolbanin J., Doosti M.-H., Baradaran B., Amani M., Azarfarin M., Salari A.-A. Neonatal immune activation during early and late postnatal brain development differently influences depression-related behaviors in adolescent and adult C57BL/6 mice. Neuroimmunol. Neuroinflamm. 2014, 1:35.
55. Majidi-Zolbanin J., Doosti M.-H., Kosari-Nasab M., Salari A.-A. Prenatal maternal immune activation increases anxiety-and depressive-like behaviors in offspring with experimental autoimmune encephalomyelitis. Neuroscience 2015, 294:69-81.
56. Mendlowicz M.V., Stein M.B. Quality of life in individuals with anxiety disorders. Am. J. Psychiatry 2000, 157(May (5)):669-682.
57. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
58. Miyaoka T., Wake R., Furuya M., Liaury K., Ieda M., Kawakami K., Tsuchie K., Taki M., Ishihara K., Araki T. Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2012, 37:222-226.
59. Molina-Hernández M., Tellez-Alcántara N.P., Pérez-García J., Olivera-Lopez J.I., Jaramillo-Jaimes M.T. Antidepressant-like actions of minocycline combined with several glutamate antagonists. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2008, 32:380-386.
60. Monje M.L., Toda H., Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003, 302:1760-1765.
61. Monteggia L.M., Luikart B., Barrot M., Theobold D., Malkovska I., Nef S., Parada L.F., Nestler E.J. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol. Psychiatry 2007, 61:187-197.
62. Munck A., Guyre P., Holbrook N. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 1984, 5:25-44.
63. Murray C.L., Obiang P., Bannerman D., Cunningham C. Endogenous IL-1 in cognitive function and anxiety: a study in IL-1RI-/- mice. PLoS One 2013, 8. e78385.
64. Nagano M., Liu M., Inagaki H., Kawada T., Suzuki H. Early intervention with fluoxetine reverses abnormalities in the serotonergic system and behavior of rats exposed prenatally to dexamethasone. Neuropharmacology 2012, 63:292-300.
65. O'connor J., Lawson M., Andre C., Moreau M., Lestage J., Castanon N., Kelley K., Dantzer R. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2, 3-dioxygenase activation in mice. Mol. Psychiatry 2009, 14:511-522.
66. Owen B.M., Eccleston D., Ferrier I.N., Young A.H. Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr. Scand. 2001, 103:226-228.
67. Pae C.-U., Marks D.M., Han C., Patkar A.A. Does minocycline have antidepressant effect?. Biomed. Pharmacother. 2008, 62:308-311.
68. Pariante C.M., Lightman S.L. The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 2008, 31:464-468.
69. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
70. Ravindran L., Stein M. The pharmacologic treatment of anxiety disorders: a review of progress. J. Clin. Psychiatry 2010, 71:839.
71. Rayen I., Van Den Hove D.L., Prickaerts J., Steinbusch H.W., Pawluski J.L. Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS One 2011, 6. e24003.
72. Richtand N.M., Ahlbrand R., Horn P., Tambyraja R., Grainger M., Bronson S.L., McNamara R.K. Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response. Physiol. Behav. 2012, 106:171-177.
73. Rossi S., Sacchetti L., Napolitano F., De Chiara V., Motta C., Studer V., Musella A., Barbieri F., Bari M., Bernardi G. Interleukin-1β causes anxiety by interacting with the endocannabinoid system. J. Neurosci. 2012, 32:13896-13905.
74. Salari A.-A., Bakhtiari A., Homberg J.R. Activation of GABA-A receptors during postnatal brain development increases anxiety-and depression-related behaviors in a time-and dose-dependent manner in adult mice. Eur. Neuropsychopharmacol. 2015, 25:1260-1274.
75. Salim S., Chugh G., Asghar M. Inflammation in anxiety. Adv. Protein Chem. Struct. Biol. 2012, 88:1-25.
76. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
77. Simen B.B., Duman C.H., Simen A.A., Duman R.S. TNFα signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol. Psychiatry 2006, 59:775-785.
78. Smith P.L., Hagberg H., Naylor A.S., Mallard C. Neonatal peripheral immune challenge activates microglia and inhibits neurogenesis in the developing murine hippocampus. Dev. Neurosci. 2014, 36:119-131.
79. Soczynska J.K., Mansur R.B., Brietzke E., Swardfager W., Kennedy S.H., Woldeyohannes H.O., Powell A.M., Manierka M.S., McIntyre R.S. Novel therapeutic targets in depression: minocycline as a candidate treatment. Behav. Brain Res. 2012, 235:302-317.
80. Sominsky L., Walker A., Ong L., Tynan R., Walker F., Hodgson D. Increased microglial activation in the rat brain following neonatal exposure to a bacterial mimetic. Behav. Brain Res. 2012, 226:351-356.
81. Song C., Halbreich U., Han C., Leonard B., Luo H. Imbalance between pro-and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment. Pharmacopsychiatry 2009, 42:182-188.
82. Stetler C., Miller G.E. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom. Med. 2011, 73:114-126.
83. Toneatto T., Nguyen L. Does mindfulness meditation improve anxiety and mood symptoms? a review of the controlled research. Can. J. Psychiatry 2007, 52:260.
84. Tsigos C., Chrousos G.P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res. 2002, 53:865-871.
85. Tuglu C., Kara S.H., Caliyurt O., Vardar E., Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology 2003, 170:429-433.
86. Walker A., Nakamura T., Hodgson D. Neonatal lipopolysaccharide exposure alters central cytokine responses to stress in adulthood in Wistar rats. Stress 2010, 13:506-515.
87. Walker A.K., Hawkins G., Sominsky L., Hodgson D.M. Transgenerational transmission of anxiety induced by neonatal exposure to lipopolysaccharide: implications for male and female germ lines. Psychoneuroendocrinology 2012, 37:1320-1335.
88. Walker F.R., March J., Hodgson D.M. Endotoxin exposure in early life alters the development of anxiety-like behaviour in the Fischer 344 rat. Behav. Brain Res. 2004, 154:63-69.
89. Zheng L.-S., Kaneko N., Sawamoto K. Minocycline treatment ameliorates interferon-alpha-induced neurogenic defects and depression-like behaviors in mice. Front. Cell. Neurosci. 2015, 9.
90. Zhu F., Zheng Y., Ding Y., Liu Y., Zhang X., Wu R., Guo X., Zhao J. Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats. PLoS One 2014, 9. e93966.
91. Zhu F., Zheng Y., Liu Y., Zhang X., Zhao J. Minocycline alleviates behavioral deficits and inhibits microglial activation in the offspring of pregnant mice after administration of polyriboinosinic-polyribocytidilic acid. Psychiatry Res. 2014, 219:680-686.
92. Zunszain P.A., Anacker C., Cattaneo A., Choudhury S., Musaelyan K., Myint A.M., Thuret S., Price J., Pariante C.M. Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology 2012, 37:939-949.